Variant Synonymizer: Platform to identify mutations defined in different ways is available now!

VarSy

Over 2,000 gene–disease validation summaries are now available—no login required!

Browse Summaries

VCL – Hypertrophic Cardiomyopathy

Heterozygous missense variants in VCL have been reported in unrelated individuals with Hypertrophic Cardiomyopathy in the absence of known sarcomeric gene mutations. In a cohort of 228 genotype‐negative HCM patients, a novel c.829C>A (p.Leu277Met) variant was identified in one patient with severe mid‐ventricular obstruction and absent in 400 reference alleles (PMID:16712796). In a separate screen of 389 HCM probands, three additional missense changes (p.Ala934Val, p.Pro943Ala, p.Arg975Trp) were found in four patients but showed no robust pedigree segregation (PMID:16236538). No affected relatives with segregating VCL variants have been reported.

Functional studies support a pathogenic role for VCL variants in cardiac muscle remodeling. Immunohistochemistry of myectomy tissue from variant carriers reveals reduced vinculin at intercalated discs (PMID:16712796). In vitro assays and molecular modeling demonstrate that mutations in the metavinculin tail domain (e.g., p.Arg975Trp) disrupt F‐actin bundling and dimerization, leading to aberrant cytoskeletal assemblies consistent with hypertrophic remodeling (PMID:30844403). Deep‐intronic VCL variants have also been prioritized in HCM cohorts, though co‐segregation and functional validation remain limited (PMID:28797094).

Overall, the association between VCL and HCM is classified as Limited based on five unrelated probands, absence of segregation data, and supportive but non‐definitive functional evidence. Key take-home: VCL genetic testing may uncover rare risk alleles in HCM, but interpretation requires caution due to limited case numbers and lack of familial segregation.

References

  • Biochemical and biophysical research communications • 2006 • A missense mutation in a ubiquitously expressed protein, vinculin, confers susceptibility to hypertrophic cardiomyopathy. PMID:16712796
  • Molecular genetics and metabolism • 2006 • Identification of a metavinculin missense mutation, R975W, associated with both hypertrophic and dilated cardiomyopathy. PMID:16236538
  • Journal of molecular biology • 2019 • Cardiomyopathy Mutations in Metavinculin Disrupt Regulation of Vinculin-Induced F-Actin Assemblies. PMID:30844403
  • PloS one • 2017 • Whole gene sequencing identifies deep-intronic variants with potential functional impact in patients with hypertrophic cardiomyopathy. PMID:28797094

Evidence Based Scoring (AI generated)

Gene–Disease Association

Limited

Five unrelated probands (c.829C>A, p.Leu277Met; p.Ala934Val; p.Pro943Ala; p.Arg975Trp) with HCM, no segregation data, supportive functional assays

Genetic Evidence

Limited

Case‐level data in 5 probands, absence of family segregation

Functional Evidence

Moderate

Immunohistochemistry and in vitro F‐actin bundling assays concordantly demonstrate functional impact of VCL variants